Molnupiravir-d7

• CAT Number: S000095
• Molecular Formula: C13H12D7N3O7
• Molecular Weight: 336.35
• Purity: ≥95%
• Target: SARS-CoV
• IUPAC Name: [(2R,3R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2,3,3,3-tetradeuterio-2-(trideuteriomethyl)propanoate
• InChI: InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9+,10?,11-/m1/s1/i1D3,2D3,6D
• InChIKey: HTNPEHXGEKVIHG-MBRGINTQSA-N
• SMILES: [2H]C([2H])([2H])C([2H])(C(=O)OC[C@@H]1[C@@H](C([C@@H](O1)N2C=CC(=NC2=O)NO)O)O)C([2H])([2H])[2H]

Molnupiravir-d7 is a high-purity deuterated antiviral compound used in advanced pharmaceutical research. This isotopically labeled version of Molnupiravir is essential for studies involving antiviral drug metabolism, pharmacokinetics, and therapeutic efficacy. With seven deuterium atoms, it provides precise and reliable results, ensuring accurate analytical outcomes. Its enhanced stability and consistency make it suitable for various experimental setups. Ideal for virology and drug development research, Molnupiravir-d7 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for cutting-edge scientific investigations.